# Mechanisms of Pertussis Toxin Action: ADP-Ribosylation and Its Role in Pertussis Pathogenesis

**Authors:** Qing Tang, Ho Yung Chan, Yanxi Huang, Yung H. Wong

PMC · DOI: 10.3390/toxins18030148 · Toxins · 2026-03-18

## TL;DR

This paper explains how pertussis toxin disrupts host cell signaling through ADP-ribosylation and other mechanisms to aid bacterial infection.

## Contribution

The paper clarifies the dual functionality of pertussis toxin, distinguishing cAMP-dependent and cAMP-independent effects.

## Key findings

- Pertussis toxin's A subunit ADP-ribosylates Gαi proteins, leading to increased cAMP levels.
- The B oligomer of pertussis toxin can trigger signaling independently of ADP-ribosylation.
- Pertussis toxin works with adenylate cyclase toxin to subvert immune defenses.

## Abstract

Pertussis toxin (PTx) is a major virulence factor of Bordetella pertussis and an AB5-type exotoxin that disrupts host signaling. Its enzymatic A subunit ADP-ribosylates the α-subunit of inhibitory G proteins (Gαi), preventing them from mediating receptor-induced inhibition of adenylyl cyclase (AC). This leads to unrestrained cAMP accumulation in host cells, a canonical mechanism underlying many pertussis disease manifestations. PTx works in concert with the bacterium’s adenylate cyclase toxin (ACT) to subvert immune defenses and establish infection. Interestingly, PTx exerts both cAMP-dependent and cAMP-independent effects. In addition to the well-known cAMP-mediated pathway, PTx’s B oligomer can engage host cell surface receptors to trigger signaling cascades independent of the A subunit’s catalytic activity. Such B oligomer-mediated pathways modulate cellular responses in the absence of ADP-ribosylation. This review provides a comprehensive analysis of PTx’s dual functionality, distinguishing its Gi protein-dependent elevation of cAMP from the noncanonical activities of the B oligomer. It also highlights how disruption of constitutive Gi signaling and the interplay between PTx and ACT shape host–pathogen interaction in pertussis pathogenesis.

## Linked entities

- **Proteins:** GAI (DELLA protein GAI)
- **Diseases:** pertussis (MONDO:0005077)
- **Species:** Bordetella pertussis (taxon 520)

## Full-text entities

- **Genes:** MT1L (metallothionein 1L (pseudogene)) [NCBI Gene 4500] {aka MT1, MT1LP, MT1R, MTF}, Egf (epidermal growth factor) [NCBI Gene 25313], DRD2 (dopamine receptor D2) [NCBI Gene 1813] {aka D2DR, D2R}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Rapgef3 (Rap guanine nucleotide exchange factor (GEF) 3) [NCBI Gene 223864] {aka 2310016P22Rik, 9330170P05Rik, Epac, Epac1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, Tsc2 (TSC complex subunit 2) [NCBI Gene 24855] {aka Rc}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Ngf (nerve growth factor) [NCBI Gene 310738] {aka Ngfb, beta-NGF}, Rps6kb1 (ribosomal protein S6 kinase B1) [NCBI Gene 83840] {aka p70 S6K-alpha}, GNAI1 (G protein subunit alpha i1) [NCBI Gene 2770] {aka Gi, HG1B, NEDHISB}, GPR166P (G protein-coupled receptor 166, pseudogene) [NCBI Gene 442206] {aka GPCR, PGR9}, ADRB2 (adrenoceptor beta 2) [NCBI Gene 154] {aka ADRB2R, ADRBR, ARB2, B2AR, BAR, BETA2AR}, Epidermal growth factor [NCBI Gene 108348113], Gnai3 (G protein subunit alpha i3) [NCBI Gene 14679] {aka Galphai3, Gnai-3, Hg1a}
- **Diseases:** paralysis (MESH:D010243), tissue (MESH:D017695), cyanosis (MESH:D003490), vomiting (MESH:D014839), hypersensitivity (MESH:D004342), hypoglycemia (MESH:D007003), inflammation (MESH:D007249), histamine (MESH:D003027), cough (MESH:D003371), fever (MESH:D005334), heart failure (MESH:D006333), pulmonary hypertension (MESH:D006976), immune dysregulation (OMIM:614878), pulmonary inflammation (MESH:D011014), hypotension (MESH:D007022), injury to (MESH:D014947), leukocytosis (MESH:D007964), respiratory infection (MESH:D012141), Infections (MESH:D007239), metabolic dysregulation (MESH:D021081), ACT (MESH:C567228), inflammatory cytokines (MESH:D000080424), neurological complication (MESH:D002493), lymphocytosis (MESH:D008218), PTx (MESH:D014917), immune dysfunction (MESH:D007154)
- **Chemicals:** DAG (MESH:D004075), GTP (MESH:D006160), glutathione (MESH:D005978), GlcNAc (MESH:D000117), cysteine (MESH:D003545), histamine (MESH:D006632), Glu (MESH:D018698), NAD (MESH:D009243), S1P (MESH:C060506), LOS (MESH:C023023), melatonin (MESH:D008550), nicotinamide (MESH:D009536), ADP-ribose (MESH:D000246), amines (MESH:D000588), ATP (MESH:D000255), forskolin (MESH:D005576), GDP (MESH:D006153), Gln (MESH:D005973), Galphai (-), prostaglandins (MESH:D011453), Calcium (MESH:D002118), DAP (MESH:C041756), HEPES (MESH:D006531), lipid (MESH:D008055), holotoxin (MESH:C001883), ADP (MESH:D000244), adenosine (MESH:D000241), IP3 (MESH:D015544)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Bordetella bronchiseptica (species) [taxon 518], Bordetella parapertussis (species) [taxon 519], Mus musculus (house mouse, species) [taxon 10090], Bordetella pertussis (species) [taxon 520], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** E129, G352 in the C, S52F, C41S
- **Cell lines:** 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029963/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13029963/full.md

## References

153 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029963/full.md

---
Source: https://tomesphere.com/paper/PMC13029963